Hero image with Pittsburgh background pittplusme.org/study/2121

STUDY BASICS

Are you 18-75 and diagnosed with a type of liver disease called non-alcoholic steatohepatitis (NASH)? You may be able to participate in a study to test two investigational drugs (study drugs) being developed as potential options to treat patients with NASH with liver fibrosis. This study involves at least 16 visits over up to 68 months. Compensation is provided.


IRB: 20200277
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, DOSERANGING, DOSE-FINDING, PARALLEL GROUP STUDY TO ASSESS EFFICACY AND SAFETY OF PF-06865571 (DGAT2I) ALONE AND WHEN COADMINISTERED WITH PF-05221304 (ACCI) IN ADULT PARTICIPANTS WITH BIOPSY-CONFIRMED NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS STAGE 2 OR 3

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit pittplusme.org/study/2121 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe